A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

NCT07710196 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinitis Pigmentosa (RP)
Usher Syndrome

Interventions

DRUG: Placebo
DRUG: NPI-001

Sponsor

Nacuity Pharmaceuticals, Inc.

Collaborators

[object Object]